Bethesda, Md., July 15, 2010 – The Parenteral Drug Association (PDA) is proud to announce key industry and government leaders as presenters at the 2010 PDA/FDA Joint Regulatory Conference, Sept. 13-16, Renaissance Washington Hotel in Washington, D.C.
The Parenteral Drug Association (PDA) is pleased to announce the addition of key industry representatives as well as government officials to the already impressive speaker line-up. “PDA has been actively involved with the latest technology and regulations concerning high-quality pharmaceutical and biopharmaceutical production. With the high profile compliance issues and the “mega” mergers and acquisitions that our industry is experiencing, now is the time to focus on strengthening Quality Systems, and thereby safeguarding the public interest,” said PDA President Richard M. Johnson. “We are pleased to host such high level speakers at our meeting,” he added.
David Brennan, CEO, AstraZeneca will speak on the topic of Patient Responsibility.
Pat Yang, Head of Pharma Technical Operations, F. Hoffmann- La Roche will discuss the challenges of managing merging global organizations. Barbara A. Ryan, Managing Director, Research Analyst, Deutsche Bank Securities, Inc. will be back to discuss insights, trends and the financial outlook for the pharmaceutical industry, and Vicki L. Seyfert-Margolis, PhD,FDA will be part of a dialogue and is a Senior Advisor within Science Innovation and Policy for the FDA Commissioner’s Office.
FDA Commissioner, Dr. Margaret Hamburg will be delivering the opening Keynote presentation.
For more information, go to www.pda.org/pdafda2010. Press inquiries should be directed to PDA’s Adrienne Fierro,firstname.lastname@example.org.